{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-038694","form_type":"8-K","ticker":"HOTH","cik":"0001711786","company_name":"Hoth Therapeutics, Inc.","filed_at":"2025-05-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.433274+00:00","generated_at":"2026-05-22T22:56:03.752254+00:00","sec_items":["8.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Hoth subsidiary's PCT patent application for hair loss treatment fee-confirmed","bullets":["Merveille.ai received USPTO confirmation that PCT/US2025/022598 fees were paid in full.","Application covers treatment and prevention of hair loss, with priority date April 5, 2024.","Filing supports Merveille.ai's intellectual property strategy for therapeutic innovation."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-038694","json":"https://secwatch.observer/filing/0001213900-25-038694.json","markdown":"https://secwatch.observer/filing/0001213900-25-038694.md","text":"https://secwatch.observer/filing/0001213900-25-038694.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1711786/000121390025038694/0001213900-25-038694-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1711786/000121390025038694/ea0240533-8k_hoth.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T22:56:03.752254+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}